ICON
Shire signs strategic partnership deal with ICON
January 10, 2012Research and Development ICON, Shire
Contract research organisation ICON has signed a strategic partnership with Shire Specialty Pharmaceuticals to be the sole global provider of …
Pfizer simplifies contract research with Parexel and Icon
May 27, 2011Research and Development ICON, Parexel, Pfizer, cros
Parexel and Icon have been chosen as Pfizer’s two long-term partners, in a move by the US pharma company to …
Contract research news in brief
January 24, 2011Research and Development AMRI, Applied Clinical Intelligence, Cenix Bioscience, Clinipace Worldwide, ICON, PPD, Pacific Biomarkers, monoclonal antibody
PPD sets up a monoclonal antibody JV in Singapore, plus updates from Icon plc, Cenix Bioscience, Clinipace Worldwide, Pacific Biomarkers, …
Contract research news in brief
November 26, 2010Research and Development Chemir Analytical Services, Convergence, Cyanta, ICON, Iris Pharma, PRA, Proteome Sciences, Selcia, chiltern, contract research
Our round-up of recent development in the contract research sector includes updates from Selcia, Iris Pharma, ICON, Proteome Sciences, Chiltern, …
Contract research news in brief
July 13, 2010Research and Development Charles River Laboratories, ClinTec, ICON, Quintiles, Synexus, Technical Resources International, WuXi
Charles River places its proposal to merge with China’s WuXi PharmaTech in front of its shareholders, while ClinTec and Synexus …
Contract research news in brief
June 18, 2010Research and Development CRO, ClinStar, Covance, ICON, Parexel, Phlexglobal, Quintiles, chiltern, contract research
Good news abounds in the CRO sector at the moment, with a raft of business expansions, investments, and new contracts …
Mixed fortunes for major CROs in Q1
May 7, 2010Research and Development CRO, Covance, ICON, PPD, Parexel, contact research, contract research, contract research organisation
Leading contract research organisations (CROs) reported a mixed bag of financial results for the first three months of 2010, although …
ICON and Tigermed forge China alliance
April 7, 2010Research and Development CRO, China, ICON
Contract research organisation ICON is to team up with Tigermed Consulting, a clinical services company based in China. The alliance …
ICON sees revenues rise in 2009
March 1, 2010Research and Development CRO, ICON
Contract research organisation ICON saw its revenues increase 3% to $888 million last year and says it is “positive, though …
ICON promotes Tom O’Leary
February 9, 2010Research and Development ICON, appointment, research and development
Tom O’Leary has been appointed president of ICON Central Laboratories, succeeding Bob Scott-Edwards. Scott-Edwards had held the role since August …
Bruce Given appointed chairman of ICON
January 18, 2010Research and Development ICON, appointment, research and development
Irish contract research organisation ICON has appointed Bruce Given chairman.He succeeds out-going chairman John Climax who co-founded the company in 1990 …
Contract research news in brief
December 22, 2009Research and Development AAIPharma, Benten BioServices, CRO, Covance, ICON, PharmaVigilant, Phase Forward, SynRG
Our round-up of developments in the contract research sector includes updates from ICON, SynRG, AAIPharma, Covance, Benten BioServices, Phase Forward …
ICON investments will come to fruition in 2010
December 16, 2009Research and Development ICON, Manchester, translational
Irish contract research organisation ICON has provided additional details on its new translational medicine unit in Manchester, UK, first announced …
Clinical research news in brief
November 30, 2009Research and Development CRO, Clinipace, ICON, Parexel
Pharmafocus’ latest round-up of clinical research news includes a new US registry to aid patient recruitment, alliances for ICON, Parexel …
Observational studies will help answer growing safety demands
September 8, 2009Research and Development ICON, drug safety
The pharmaceutical industry is ready to adapt to growing drug safety requirements, but understanding of how it can capture safety …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
